当前位置: X-MOL 学术Nat. Med. › 论文详情
Our official English website, www.x-mol.net, welcomes your feedback! (Note: you will need to create a separate account there.)
Endpoints and estimands: understanding trials of weight-loss drugs
Nature Medicine ( IF 58.7 ) Pub Date : 2022-10-10 , DOI: 10.1038/s41591-022-02032-6
Amanda I Adler 1
Affiliation  

Challenges that characterize weight-loss drug trials necessitate good trial design — as highlighted by the STEP 5 trial of semaglutide.

中文翻译:

终点和估计值:了解减肥药的试验

减肥药物试验所面临的挑战需要良好的试验设计——正如 semaglutide 的 STEP 5 试验所强调的那样。
更新日期:2022-10-11
down
wechat
bug